LD-2 disclosure · 2nd Quarter - Report
BIOGENIDEC
Client
- Name
- BIOGENIDEC
- Description
- Medical Technology Firm
- Location
- * Undetermined
Registrant
- Description
- Government relations firm
- Location
- WASHINGTON, District of Columbia, United States of America
Lobbying activities
3 issuesCopyright/Patent/Trademark
Monitoring federal legislation related to Patent Reform Act of 2007 (HR1908/S1145) and other health care issues and advise client as it affects them.
LobbyistsDARREN WILLCOX
TargetedSENATE · HOUSE OF REPRESENTATIVES · Executive Office of the President (EOP) · Commerce, Dept of (DOC) · Health & Human Services, Dept of (HHS)
Health Issues
Monitoring implementation and legislation affecting the Medicare program, the Prescription Drug User Fee Act, legislation to create a regulatory pathway for biosimiliars (Pathway for Biosimilars Act (H.R. 5629)) and other major health care initiatives before Congress.
LobbyistsDARREN WILLCOX
TargetedSENATE · HOUSE OF REPRESENTATIVES · Executive Office of the President (EOP) · Commerce, Dept of (DOC) · Health & Human Services, Dept of (HHS)
Medicare/Medicaid
Monitoring implementation and legislation affecting the Medicare program, the Prescription Drug User Fee Act, legislation to create a regulatory pathway for biosimiliars (Pathway for Biosimilars Act (H.R. 5629)) and other major health care initiatives before Congress.
LobbyistsDARREN WILLCOX